AlkB Homolog 5 Regulates Hexokinase 2‐Mediated Glycolysis and Participates in the Progression of Endometriosis
The FASEB Journal · 2025
DOI: 10.1096/fj.202500614r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Jun-Jun Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Endometriosis, Hexokinase, Glycolysis, AlkB Homolog 5, RNA Demethylase. Die Arbeit nennt 65 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), National Natural Science Foundation of China.
Abstract (Originalsprache)
Endometriosis is a common gynecological endocrine disease with unclear pathogenesis. Evidence suggests enhanced aerobic glycolysis in ectopic endometrium of endometriosis. The role of N6‐methyladenosine (m6A) modification in female reproductive diseases has been revealed in recent years, and it is involved in the regulation of glycolysis in a variety of diseases. Here, we investigated the regulatory effect of m6A modification on glycolysis and its role in endometriosis. RNA sequencing of ectopic endometrium of endometriosis and normal endometrium revealed that hexokinase 2 (HK2) a glycolysis‐related gene, was significantly up‐regulated in ectopic endometrium of endometriosis. Meanwhile, this result was supported by immunohistochemistry. Subsequently, we found that AlkB homolog 5 (ALKBH5) could upregulate HK2 in human endometrial stromal cells (THESCs). Up‐regulation of ALKBH5 promoted glycolysis, invasion, and migration of THESCs, which could be alleviated by 2‐Deoxy‐d‐glucose (2‐DG). Furthermore, knockdown of HK2 in THESCs overexpressing ALKBH5 significantly attenuated the promoting effects of ALKBH5 on glycolysis, migration, and invasion of THESCs. Moreover, an ALKBH5 inhibitor, 5‐Carboxy‐8‐hydroxyquinoline (IOX1) was found to inhibit the progression of endometriosis and glycolysis in a mouse model of endometriosis. In conclusion, ALKBH5 promoted glycolysis by up‐regulating HK2 and contributed to the progression of endometriosis. ALKBH5 may be a new target for the treatment of endometriosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
- Wuhan Fourth Hospital, Wuhan, Hubei, China.
- Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
ORCID-Profile: Yu-Qing Fang, Heng-Wei Liu, Yi Liu
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- National Natural Science Foundation of China
Zitieren
APA
Liu, J. J., Fang, Y. Q., Xiong, W. Q., Liu, H. W., Li, J. Y., Wang, X. P., Wang, H. J., Zhang, L., & Liu, Y. (2025). AlkB Homolog 5 Regulates Hexokinase 2‐Mediated Glycolysis and Participates in the Progression of Endometriosis. The FASEB Journal. https://doi.org/10.1096/fj.202500614r
Vancouver
Liu JJ, Fang YQ, Xiong WQ, Liu HW, Li JY, Wang XP, et al. AlkB Homolog 5 Regulates Hexokinase 2‐Mediated Glycolysis and Participates in the Progression of Endometriosis. The FASEB Journal. 2025. doi:10.1096/fj.202500614r
BibTeX
@article{Liu2025,
author = {Liu, Jun-Jun and Fang, Yu-Qing and Xiong, Wen-Qian and Liu, Heng-Wei and Li, Jing-Yi and Wang, Xiu-Ping and Wang, Hua-Jing and Zhang, Ling and Liu, Yi},
title = {AlkB Homolog 5 Regulates Hexokinase 2‐Mediated Glycolysis and Participates in the Progression of Endometriosis},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202500614r}
}
EUVIMED